tradingkey.logo

tradingkey.logo
怜玢


Autonomix Medical Inc

AMIX
りォッチリストに远加
0.325USD
+0.003+0.90%
終倀 05/15, 16:00ET15分遅れの株䟡
3.71M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Autonomix Medical Inc 䌁業名

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Incの䌁業情報


䌁業コヌドAMIX
䌚瀟名Autonomix Medical Inc
䞊堎日Jan 29, 2024
最高経営責任者「CEO」Hauser (Bradley)
埓業員数8
蚌刞皮類Ordinary Share
決算期末Jan 29
本瀟所圚地21 Waterway Ave, Suite 300
郜垂THE WOODLANDS
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号77380
電話番号18322777816
りェブサむトhttps://autonomix.com/
䌁業コヌドAMIX
䞊堎日Jan 29, 2024
最高経営責任者「CEO」Hauser (Bradley)

Autonomix Medical Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--

収益内蚳

䌚瀟から関連デヌタがただ開瀺されおいたせん。
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Thu, Feb 19
曎新時刻: Thu, Feb 19
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Klemp (Walter V.)
1.32%
BioStar Ventures III, L.P.
1.06%
Heights Capital Management, Inc.
1.02%
Toth (Landy)
0.89%
Mariner Wealth Advisors
0.47%
他の
95.25%
株䞻統蚈
株䞻統蚈
比率
Klemp (Walter V.)
1.32%
BioStar Ventures III, L.P.
1.06%
Heights Capital Management, Inc.
1.02%
Toth (Landy)
0.89%
Mariner Wealth Advisors
0.47%
他の
95.25%
皮類
株䞻統蚈
比率
Individual Investor
3.01%
Investment Advisor
2.29%
Corporation
1.06%
Hedge Fund
0.31%
Investment Advisor/Hedge Fund
0.21%
他の
93.13%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
42
319.97K
2.80%
-276.56K
2025Q4
39
329.96K
7.13%
--
2025Q3
39
329.96K
7.93%
+35.06K
2025Q2
35
294.92K
16.34%
-135.37K
2025Q1
30
430.29K
14.58%
+71.16K
2024Q4
29
489.76K
8.72%
+336.46K
2024Q3
25
18.30K
0.40%
+13.75K
2024Q2
19
4.55K
0.18%
+2.81K
2024Q1
10
1.66K
0.00%
+1.66K

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Klemp (Walter V.)
150.75K
1.32%
--
--
Sep 19, 2025
BioStar Ventures III, L.P.
120.82K
1.06%
--
--
Jun 30, 2025
Heights Capital Management, Inc.
116.09K
1.02%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
0.89%
--
--
Sep 19, 2025
Mariner Wealth Advisors
53.14K
0.47%
-47.50K
-47.20%
Dec 31, 2025
Foster (Jonathan P.)
36.56K
0.32%
--
--
Sep 19, 2025
Schwartz (Robert)
35.77K
0.31%
--
--
Sep 19, 2025
UBS Financial Services, Inc.
127.00
0%
+48.00
+60.76%
Dec 31, 2025
LPL Financial LLC
31.43K
0.28%
+31.43K
--
Dec 31, 2025
BMO Nesbitt Burns Inc.
25.00K
0.22%
--
--
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
日付
配圓萜ち日
皮類
比率
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
KeyAI
î™